Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jan 27;21(1):1036.
doi: 10.4102/sajhivmed.v21i1.1036. eCollection 2020.

'Covering the tail' after stopping efavirenz-based antiretroviral therapy

Gary Maartens  1
Affiliations
Editorial

'Covering the tail' after stopping efavirenz-based antiretroviral therapy

Gary Maartens. South Afr J HIV Med. .
No abstract available

PubMed Disclaimer

References

    1. Chi BH, Sinkala M, Mbewe F, et al. Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: An open-label randomised trial. Lancet. 2007;370(9600):1698–1705. 10.1016/S0140-6736(07)61605-5 - DOI - PubMed
    1. McIntyre JA, Hopley M, Moodley D, et al. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: A randomized clinical trial. PLoS Med. 2009;6(10):e1000172 10.1371/journal.pmed.1000172 - DOI - PMC - PubMed
    1. Ajibola G, Maruapula D, Rowley C, et al. ‘Drug resistance after cessation of efavirenz-based antiretroviral treatment started in pregnancy. S Afr J HIV Med. 2020;21(1), a1023 10.4102/sajhivmed.v21i1.1023 - DOI - PMC - PubMed
    1. Jackson A, Moyle G, Watson V, et al. Tenofovir, emtricitabine intracellular and plasma, and efavirenz plasma concentration decay following drug intake cessation: Implications for HIV treatment and prevention. J Acquir Immune Defic Syndr. 2013;62(3):275–281. 10.1097/QAI.0b013e3182829bd0 - DOI - PubMed
    1. Sinxadi PZ, Leger PD, McIlleron H, et al. Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa. Br J Clin Pharmacol. 2015;80(1):146–156. 10.1111/bcp.12590 - DOI - PMC - PubMed

Publication types

LinkOut - more resources